In addition, increased expression of human CD16a (FcγRIII) or mouse FcγRIV by macrophages activated with interferon-γ, induced trastuzumab-mediated antibody-dependent cellular phagocytosis of tumour cells22. The gene discussed is FCGR3A; the disease is neoplasm.